MUTATIONAL PROFILE IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROME AT THE TIME OF PROGRESSION TO ACUTE LEUKEMIA

被引：0
|
作者：
Pedrote, B. [1 ]
Falantes, J. F. [1 ]
Carrillo, E. [1 ]
Calderon-Cabrera, C. [1 ]
Espigado, I [1 ]
Perez-Simon, J. A. [1 ]
机构：
[1] Hosp Univ Virgen Rocio, Seville, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-051
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [1] Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression
    Pedrote, Begona
    Falantes, Jose Francisco
    Carrillo, Estrella
    Calderon-Cabrera, Cristina
    Marquez-Malaver, Francisco J.
    Espigado, Ildefonso
    Perez-Simon, Jose A.
    BLOOD, 2017, 130
  • [2] The role of rHuEpo in low-risk myelodysplastic syndrome patients
    Rigolin, GM
    Castoldi, G
    LEUKEMIA & LYMPHOMA, 2005, 46 (06) : 823 - 831
  • [3] Experience with the use of azacitidine in patients with low-risk myelodysplastic syndrome
    Duarte, F.
    Santos, T.
    Barbosa, M.
    Santos, T.
    Goncalves, R.
    LEUKEMIA RESEARCH, 2013, 37 : S166 - S166
  • [4] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2157 - 2164
  • [5] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    HAEMATOLOGICA, 2024, 109 (07) : 2157 - 2164
  • [6] Impact of Erythropoietic Stimulating Agents on Mutational Composition in Patients with Low-Risk Myelodysplastic Syndromes
    Patel, Bhumika
    Saygin, Caner
    Przychodzen, Bartlomiej P.
    Kuzmanovic, Teodora
    Hirsch, Cassandra M.
    Clemente, Michael J.
    Thota, Swapna
    Nazha, Aziz
    Mikkael, Sekeres A.
    Maciejewski, Jaroslaw P.
    Carraway, Hetty E.
    BLOOD, 2016, 128 (22)
  • [7] Incorporation mutational profile might reduce the importance of blast count in prognostication of low-risk myelodysplastic syndromes
    Garcia-Culebras, Marta
    Alcalde, Patricia
    Marquez-Malaver, Francisco J.
    Carrillo, Estrella
    Soria, Elena
    Prats, Concepcion
    Morales, Rosario
    Vargas, Maria T.
    Perez-Simon, Jose Antonio
    Falantes, Jose F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1765 - 1772
  • [8] The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Larsson, Connie A.
    Cote, Gilbert
    Quintas-Cardama, Alfonso
    MOLECULAR CANCER RESEARCH, 2013, 11 (08) : 815 - 827
  • [9] Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
    Qiao, Wei
    Young, Elliana
    Feng, Chun
    Liu, Suyu
    Jin, Jeff
    Noor, Laila
    Rojas Hernandez, Cristhiam M.
    Borthakur, Gautam
    Gorlova, Olga
    Afshar-Kharghan, Vahid
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [10] Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
    Wei Qiao
    Elliana Young
    Chun Feng
    Suyu Liu
    Jeff Jin
    Laila Noor
    Cristhiam M. Rojas Hernandez
    Gautam Borthakur
    Olga Gorlova
    Vahid Afshar-Kharghan
    Experimental Hematology & Oncology, 11
12345